.-Despite increasingly frequent and longer lasting hypoxic episodes during progressive labor, the neonate is alert and vigorous at birth. We investigated whether high levels of PGs during the perinatal period assist in preserving neural function after such "stressful" hypoxic events. Visual evoked potentials (VEPs) and electroretinograms (ERGs) were recorded before and 45 min after mild moderate asphyxic hypoxia (two 4-min asphyxic-hypoxic periods induced by interrupting ventilation at 8-min intervals) in newborn piglets Ͻ12 h old treated or not treated with inhibitors of PG synthase (ibuprofen or diclofenac) with or without PG analogs. At 45 min after the hypoxic episode, P2 and b-wave amplitudes were slightly decreased and latencies were delayed. These changes in the VEP and ERG returned to near normal by 120 min. Ibuprofen and diclofenac decreased brain and retinal PG levels and markedly intensified 45 min after hypoxia-induced changes in VEP and ERG, but cerebral and retinal blood flows improved. Combined treatment with PG synthase inhibitor in combination with 16,16-dimethyl-PGE 2 (a PGE 2 analog), but not with PGI 2 and PGF 2␣ analogs, and in combination with the EP 2 receptor agonist butaprost (but not EP 1 or EP 3 agonists), prevented ibuprofen-and diclofenac-aggravated postasphyxia electrophysiological changes. In conclusion, high levels of PGE 2 in nervous tissue, via actions on EP 2 receptors, seem to contribute to preservation of neural function in the perinate subjected to frequent hypoxic events.
furthermore, the head of the perinate sustains considerable pressure, which may reduce O 2 delivery to the brain (10, 12, 34, 35) . Despite these apparent stresses, the neonate is normally vigorous and alert at birth. A number of hormones have been proposed to diminish the potentially adverse consequences of this stressful condition, such as perinatal surges in catecholamines, corticosteroids, and endorphins (19, 35, 61) . PGs, mainly PGE 2 and PGI 2 , but not thromboxane A 2 , also rise in the circulation and brain beginning with the onset of parturition, reaching their peak soon before birth (29) , and abate after birth (29, 39, 44) . However, the physiological significance of this transient rise in PGs in neural tissue of the perinate is not clear.
PGs also increase during hypoxic-asphyxic episodes (16, 54, 59) ; under these conditions, prostanoids affect cerebral vasomotor tone and participate in the hemodynamic response, facilitating O 2 delivery to the brain (8, 17, 36, 53) . In addition, prostanoids can exert important effects on the brain during development, maturation, and functioning (3, 18, 30, 33, 66) .
Some prostanoids can produce deleterious effects, whereas others may afford protection (6, 24, 42, 43) . For instance, thromboxane has largely been credited with hemodynamic compromising functions (42, 52) ; in contrast, PGE 2 and PGI 2 seem to protect neural tissue against toxicity and degeneration (1, 2, 6, 7, 14, 31, 40, 49, 51, 56, 60) , although their physiological role in vivo, especially in the perinate, has never been demonstrated.
We therefore hypothesized that the high levels of PGs during the perinatal period may assist in preserving neural function after hypoxic events; if this is the case, a reduction in PG levels would enhance posthypoxic deterioration in neural function of the perinate. PG levels are still high in newborn pigs up to 12 h after birth (23, 29, 37, 39) ; we used this model to assess the effects of PG synthase inhibitors with or without PG analogs on electrophysiological brain function by recording visually evoked potentials (VEPs) before and after a hypoxic episode. In addition, retinal function (which is integral, although separate, from that of the central nervous system) was assessed by recording electroretinograms (ERGs). Our findings support our hypothesis, i.e., that high levels of PGs, specifically PGE 2 acting apparently via EP 2 receptors, preserve electrophysiological neural (brain and retina) function in the perinate subjected to hypoxic events; this effect of PGE 2 is unrelated to improvements in cerebral and retinal blood flow (CBF and RBF, respectively).
MATERIALS AND METHODS

Preparation of animals for electrophysiological recordings
and for blood flow measurements. Forty-five newborn pigs (Ͻ12 h old, 1.2-2.2 kg) were used in the study, which conformed to the guidelines of the Animal Care Committee of Ste. Justine Hospital Research Center. Vascular catheters were placed and tracheostomy was performed as previously described (9, 21) to prepare animals for electrophysiological recordings and for blood flow measurements. One group of piglets was anesthetized with 2.5% halothane for placement of a catheter (PE-50, Becton Dickinson, Parsippany, NJ) in the femoral artery for measurement of blood pressure (BP) and blood gases (model ABL-300, Radiometer, Copenhagen, Denmark) and another in the femoral vein for drug administration. VEP and ERG were recorded in separate groups of animals, because flash parameters to evoke these distinct signals differ (see below). A group of animals was also prepared for blood flow measurements, as previously described in detail (8, 9) . Briefly, a polyethylene catheter was placed into the left ventricle via the right subclavian artery for the injection of radiolabeled microspheres, and another was placed in the proximal thoracic aorta via a femoral artery for continuous BP recording. The left subclavian artery was catheterized with a similar catheter for the withdrawal of blood samples including the reference samples and for measurements of blood gases. A small catheter was introduced into the femoral vein for administration of drugs. After catheterization, tracheostomy was performed on all animals, and the animals were ventilated with air by means of a smallanimal respirator (Harvard, South Natick, MA). After surgery, halothane was discontinued and piglets were sedated intravenously with ␣-chloralose (50 mg/kg bolus followed by an infusion of 10 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 ) and paralyzed with pancuronium (0.2 mg/kg iv). Animals were then placed under a radiant warmer to maintain their body temperature at 38°C and were allowed to recover from the surgery for 1.5 h before the start of the experiments.
Experimental protocol. Animals were randomly assigned to receive an intravenous injection of one of the following: saline (2 ml, n ϭ 14); the PG synthase inhibitors ibuprofen (40 mg/kg, n ϭ 5) or diclofenac (5 mg/kg, n ϭ 9); a combination of ibuprofen or diclofenac and stable analogs of the major PGs, PGE 2 (16,16-dimethyl-PGE 2 , 5 g/kg, n ϭ 17), PGI 2 (carbaprostacyclin, 5 g/kg, n ϭ 10), and PGF 2␣ (fenprostalene, 5 g/kg, n ϭ 10); or a combination of ibuprofen or diclofenac and a PGE 2 receptor subtype agonist, 11-deoxy-PGE 1 (an EP 2 , EP 3 , and EP 4 agonist, 10 g/kg, n ϭ 6), 17-phenyl trinor-PGE 2 (an EP 1 agonist, 10 g/kg, n ϭ 6), butaprost (an EP 2 agonist, 10 g/kg, n ϭ 6), and M & B-28767 (an EP 3 agonist, 5 g/kg, n ϭ 6) (11), 30 min before the asphyxichypoxic episode. All doses are known to affect PG levels and to have effects on the piglet brain (21, 37, 39, 50).
Newborn piglets were subjected to two 4-min periods of asphyxic hypoxia 8 min apart by interruption of ventilation (9) ; the duration of these episodes approximates the progressively prolonged hypoxemia associated with increasing uterine contractions in labor (4) and, in other species, does not yield permanent neurofunctional changes (45, 55) . VEP, ERG, CBF, and RBF were measured before and 45 min after the asphyxic-hypoxic episode; drugs had no effect on basal VEP and ERG (see RESULTS). VEP was also measured 120 min after the asphyxia to verify that the asphyxia did not yield permanent changes. At the end of the experiments (45 and 120 min after asphyxia), animals were killed with pentobarbital sodium (120 mg/kg), and neural tissues were obtained for PG measurements; some animals were killed before asphyxia for determination of basal PG levels.
VEP. VEP is a reliable and sensitive parameter by which to evaluate neurological functional alterations (46, 65) . Flash VEPs in newborn pigs were recorded using a subdermal needle electrode (Grass Instruments, Quincy, MA) placed over the occipital region (3.5 mm right of midline) (58) . The reference electrode was located on the right external ear, and the right paw served as the ground electrode. Electrode impedance was kept below 5 k⍀. The head of the animal was adjusted in the center of a Ganzfeld stimulator (LKC Technologies, Gaithersburg, MD), and one eye was kept open with use of a lid retractor. The intensity of the flash stimulus (Grass Instrument) was 3.65 cd ⅐ s ⅐ m Ϫ2 attenuated by 2 log units to enhance sensitivity and was delivered by the Ganzfeld stimulator. The VEP were recorded with a signal averager (sweep time 500 ms, recording bandwidth 1-100 Hz, rate 1.3/s; Epic 2000, LKC Technologies). At least two traces were recorded for each condition, and average latencies and amplitudes of P2 waves [from the first most-negative deflection (N1) to the first most-positive deflection] were determined; this wave is reliable and is always present in neonates (58) (P1 is small and at times difficult to detect). Control recordings in response to flash stimuli were also obtained by shielding the lamp.
ERG measurements. ERG were also recorded as previously described using corneal contact lens electrodes (ERG jet, Universo, La Chaux-De Fonds, Switzerland) filled with 2% hydroxypropylmethyl cellulose (21, 22) . The reference electrode was placed on the forehead and the ground electrode on the right ear of the animal. The head of the animal was positioned in the center of a Ganzfeld stimulator. Scotopic ERGs were obtained after 40 min of dark adaptation. The intensity of the flash stimulus was adjusted at 3.65 cd ⅐ s ⅐ m Ϫ2 . The ERG responses were amplified using an Epic 2000 electrodiagnostic instrument with a bandwidth of 0.3-500 Hz. A total of 10 responses per condition were averaged and stored on computer disks for subsequent analysis. The amplitude of the a-wave was calculated as the difference in voltage from the baseline to the most-negative deflection. The b-wave amplitude was measured from the most-negative deflection of the ERG to the peak of the positive deflection. ERG parameters were not altered by simple administration of drugs. PGE 2 measurements. PGE 2 levels were measured in brain and retinal tissue of piglets treated with saline or ibuprofen and subjected to asphyxia. PGs were extracted on octadecylsilyl silica columns and determined by RIA, as described previously (9, 21, 22, 37) .
Measurement of CBF and RBF. CBF and RBF were determined using the radionuclide-labeled microsphere technique (8, 9) . Briefly, microspheres (ϳ10 6 , 15 m diameter) labeled with 141 Ce, 113 Sn, or 85 Sr were injected in a random sequence into the left ventricle. Withdrawal of reference blood samples from the left subclavian artery catheter was started 10 s before injection of each type of microsphere and was continued for 70 s at a rate of 2 ml/min with use of a Harvard infusion-withdrawal pump. After the experiment, animals were killed with excess pentobarbital sodium, the location of the catheters was verified, and the occipital brain cortex and retina were removed and weighed. Radioactivity in tissues and reference blood samples was counted in a gamma scintillation counter (Cobra II, Canberra Packard, Meridien, CT). Blood flow (ml ⅐ min Ϫ1 ⅐ 100 g Ϫ1 ) was calculated as (counts per minute per 100 g of tissue ϫ reference blood withdrawal rate)/(counts per minute in reference blood) with use of the computer system on-line with the counter (PCGERDA, Charlottesville, VA).
Chemicals. Butaprost and M & B-28767 were gifts from Miles (West Haven, CT) and Rhône-Poulenc Rorer (Dagenham Essex, UK), respectively. The following agents were purchased: diclofenac, ibuprofen, ␣-chloralose, and pancuronium from Sigma Chemical (St. Louis, MO); 16,16-dimethyl-PGE 2 , carbaprostacyclin, 11-deoxy-PGE 1 , and 17-phenyl trinor-PGE 2 from Cayman Chemical (Ann Arbor, MI); fenprostalene from Syntex (Mississauga, ON, Canada); RIA kits for PGE 2 from Advanced Magnetics (Boston, MA); radiolabeled microspheres from DuPont-New England Nuclear (Boston, MA); and all other chemicals from Fisher Scientific (Montreal, PQ, Canada).
Statistical analysis. Data were analyzed by ANOVA with factoring for time and treatment group. Post hoc comparisons among means were done by the Tukey-Kramer method. Statistical significance was set at P Յ 0.05. Values are means ϮSE; n is the number of animals.
RESULTS
Arterial blood gases, pH, mean BP, and tissue PG levels. Asphyxia, as expected, decreased arterial blood PO 2 , pH, and mean BP and increased blood PCO 2 in all groups of animals ( Table 1) ; these parameters returned to preasphyxia levels 45 min after the end of asphyxic episodes. Baseline values and asphyxic changes were unaltered by ibuprofen or ibuprofen ϩ 16,16-dimethyl-PGE 2 . PGE 2 levels in brain and retina increased 45 min after the hypoxic-asphyxic episodes and approached basal values by 120 min; ibuprofen markedly reduced PGE 2 concentrations (Fig. 1) .
Effects of PGs and/or PG synthase inhibitors on VEP. The amplitude of the P2 wave was slightly decreased and latency was prolonged 45 min after asphyxic episodes. These changes were significantly intensified by pretreatment with ibuprofen (Fig. 2) ; ibuprofen did not alter basal VEP (Fig. 2, A and B) . VEP parameters returned to near-basal values by 120 min. To further ascertain that PGs are involved in the aggravated postasphyxia VEP changes observed in ibuprofen-treated piglets, animals were treated with a combination of ibuprofen and stable analogs of major PGs, 16,16-dimethyl-PGE 2 (a PGE 2 analog), carbaprostacyclin (a PGI 2 analog), and fenprostalene (a PGF 2␣ analog); P2 amplitude and latency changes were diminished by the addition of PGs (Fig. 2) .
Identification of PG type involved in preserving brain electrophysiological function. The type of major PG primarily responsible for the preservation of the VEP was investigated. Treatment of animals with 16,16-dimethyl-PGE 2 , but not with carbaprostacyclin or fenprostalene, significantly lessened postasphyxic effects of ibuprofen on P2 amplitude and latency (Fig. 3) . Because PGE 2 acts on four receptor subtypes (EP 1 , EP 2 , EP 3 , and EP 4 ) (11), we conducted a study to determine on which of these receptors PGE 2 acted to produce its effects on the VEP by using selective PGE 2 receptor agonists. 11-Deoxy-PGE 1 (an EP 2 , EP 3 , and EP 4 agonist) and, more importantly, the selective EP 2 agonist butaprost (11) Values are means Ϯ SE. Newborn pigs were pretreated with saline (2 ml, n ϭ 14), ibuprofen (5 mg/kg, n ϭ 5), and ibuprofen ϩ 16,16-dimethyl-PGE 2 , carbaprostacyclin (Carba-PGI 2 ), and fenprostalene (5 mg/kg each, n ϭ 4) intravenously 30 min before asphyxia. Animals were subjected to 2 sequential 4-min periods of asphyxia 8 min apart by interruption of ventilation. Values during asphyxia were obtained 15 s before the end of the 2nd asphyxic period. MBP, mean blood pressure. * P Ͻ 0.05 vs. before and after asphyxia. were as effective as 16,16-dimethyl-PGE 2 in diminishing ibuprofen-aggravated postasphyxic VEP changes (Fig. 3) . The EP 1 agonist 17-phenyl trinor-PGE 2 and the EP 3 agonist M & B-28767 did not modify ibuprofen-induced postasphyxic VEP changes; EP 4 receptors are not detectable in piglet neural parenchyma (38, 38) , and EP 4 agonists are not available. 
Effects of PG modulation on asphyxia-induced changes in the ERG.
To further assess the role of PGs in diminishing asphyxic-hypoxia-induced deterioration in neural function, electrophysiological changes in the retina (ERG), a different neural tissue, were investigated. Furthermore, to ascertain the role of PGs on the neuroelectrophysiological findings, we used a PG synthase inhibitor molecularly distinct from ibuprofen, namely, diclofenac, which does not affect basal ERG (21) . The results corroborated the VEP data. Asphyxic hypoxia caused a small decrease in amplitude and a delay in latency of the b-wave, which was augmented by diclofenac (Fig. 4) ; PGE 2 levels in the retina were markedly reduced from 417 Ϯ 84 to Ͻ190 pg/mg protein by diclofenac before and 45 min after asphyxia. Once again, 16,16-dimethyl-PGE 2 and the selective EP 2 agonist butaprost were the only PG agonists that significantly diminished the diclofenac-augmented postasphyxic changes in the ERG. Hence, PGE 2 via EP 2 receptors seems to preserve postasphyxic neural function in the perinate.
Effects of PG synthase inhibitor on postasphyxic changes in CBF and RBF. Early changes in posthypoxic neural function are often associated with compromised circulation (26, 41, 62) . CBF and RBF decreased 45 min after asphyxic hypoxia in saline-treated animals; pretreatment with ibuprofen prevented this reduction in blood flow, and addition of 16,16-dimethyl-PGE 2 did not cause further changes (Fig. 5) . Thus a decrease in PG synthesis improves postasphyxic-hypoxia circulation but degrades neural function.
DISCUSSION
PG, especially PGE 2 , levels in neural tissue markedly rise during the perinatal period (29) . The physiological reason for this rise remains unknown. The perinate encounters progressively more pronounced, frequent, and longer lasting hypoxemic events at the end of labor (4); despite such stresses, the neonate is vigorous and alert at birth. Some PGs, in particular PGE, exert cytoprotective actions (1, 2, 7, 14, 49, 60) . Using a model of mild moderate asphyxic hypoxia (28, 45, 55) , we hypothesized that high levels of PGs in the central nervous tissue of the perinate may contribute to preservation of neural function. Our findings support this hypothesis and reveal that these effects are mainly conferred by PGE 2 through its actions on EP 2 receptors.
The evidence to suggest a significant role for PGs in attenuating postasphyxic changes in central nervous system function is supported by data arising from two distinct evaluations, specifically in the brain by VEP and in the retina by ERG determinations. VEPs, as is the case for the ERGs, are reliable parameters to assess neural function (25, 46, 63, 65) . A reduction in PG levels ( Fig. 1) by treatment with molecularly unrelated cyclooxygenase inhibitors, ibuprofen and diclofenac, significantly worsened 45-min postasphyxic changes in VEP and ERG (Figs. 2 and 4) . Addition of the PGE 2 analog 16,16-dimethyl-PGE 2 prevented such deterioration in VEP and ERG; in contrast, high doses (13, 39) of agonists of other major PGs, carbaprostacyclin and fenprostalene, were ineffective.
Cyclooxygenase inhibition in hypoxic-ischemic insults may be protective in the adult (9, 15, 20, 32, 57) ; this effect has mostly been attributed to inhibition of thromboxane generation (9, 27, 42) . The consequences of increased thromboxane generation are mostly ascribed to circulatory compromise. In the present study, the immediate perinatal CBF and RBF also decreased 45 min after asphyxia (Fig. 5) , and these changes, reported to be secondary to thromboxane formation (9), were prevented by ibuprofen. However, changes in circulation may not be associated with corresponding changes in function (41, 42) . Indeed, we found that ibuprofen aggravated postasphyxic neural function in the perinate when PG, but not thromboxane, levels were very high (23, 29, 37, 39) , and 16,16-dimethyl-PGE 2 prevented the effects of cyclooxygenase inhibition (Figs. 2-4) . Interestingly, administration of pharmacological doses of PGE to adult animals subjected to hypoxic-ischemic insults may also be neuroprotective (1); consistent with these in vivo data, PGE 2 has been found to exert neuroprotective actions in vitro (1, 2, 6, 7, 14, 49, 60 ).
An important feature in this study is the identification of the PGE 2 receptor EP 2 , which apparently confers the actions of PGE 2 . This inference is based on the effects of the selective EP 2 agonist butaprost (11), which, in contrast to selective EP 1 and EP 3 agonists, reproduced actions of 16,16-dimethyl-PGE 2 ; EP 4 is not detected in newborn pig brain (38, 39) . A similar role for the EP 2 receptor has been reported in cultured neurons (2) . The mechanism by which stimulation of EP 2 leads to preservation of neural function is not clear from this study; however, certain speculations can be made. Stimulation of EP 2 receptors is coupled to cAMP formation (11) , which has been associated with cytoprotective actions (2, 56, 60) . Activation of EP 2 receptors may also lead to a reduction in influx of excess calcium (2) , which in turn may likewise contribute to preservation of neural function (48, 64) . In addition, a decrease in glutamate receptor activation by EP 2 receptors may also be beneficial (2) .
In conclusion, high levels of PGE 2 in nervous tissue, through its actions on EP 2 receptors, seem to contribute to preservation of neural function of the perinate subjected to frequent hypoxic events. During the progression of labor, as uterine contractions intensify [up to Ͼ2 min every 2 min (4)], so do the episodes of hypoxia (10, 12, 34, 35) ; commonly encountered mild moderate placental abruption can also further compromise fetal oxygenation (4) . We speculate that, in addition to other purported factors, such as catecholamines, corticosteroids, and endorphins (19, 35, 60) , the marked perinatal rise in PGE 2 may assist in providing a neuroprotective mechanism that enables the neonate to manifest the needed vigor and alertness at birth, for instance, taking the first breath. In contrast, prolonged inhibition of PGs in perinates has been associated with neural injury (47) .
